THE COMMON COLD:
There is another way.
The latest clinical research has discovered how to cut the length of time a person suffers with a cold in half by using zinc gluconate or zinc acetate lozenges.
In a randomized, double-blind, placebo study, lozenges containing 12.8 mg of zinc were compared to a placebo. The zinc group had a shorter average duration of cold symptoms. Average for the zinc group was 4.5 days - the placebo group's colds lasted 8.1 days on average.
In addition, duration of coughs was reduced from 6.3 days to 3.1 days, the duration of nasal discharge was reduced from 5.8 days to 4.1 days, and the severity of all symptoms was reduced. The study, published in the August 15, 2000 issue of Annals of Internal Medicine concluded that there is a "cure for the common cold" -- zinc lozenges.
"Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms, especially coughs," state the authors of the study headed by A.S. Prasad of Wayne State University.
In a review of all the studies on zinc lozenges published in the Journal of the American Pharmaceutical Association*, the authors came to this conclusion: "Clinical trial data support the value of zinc in reducing the duration and severity of symptoms of the common cold when administered within 24 hours of the onset of common cold symptoms."
Choosing the right lozenge: